{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:01:23Z","timestamp":1781334083525,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T00:00:00Z","timestamp":1617494400000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bcp.2020.113943","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T10:46:36Z","timestamp":1585565196000},"page":"113943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling"],"prefix":"10.1016","volume":"177","author":[{"given":"Arti","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Artham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-3363","authenticated-orcid":false,"given":"Abdulrahman","family":"Alwhaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir S.","family":"Adil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3017-0230","authenticated-orcid":false,"given":"Payaningal R.","family":"Somanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2020.113943_b0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bcp.2020.113943_b0010","unstructured":"C. Fitzmaurice, D. Abate, N. Abbasi, H. Abbastabar, F. Abd-Allah, O. Abdel-Rahman, A. Abdelalim, A. Abdoli, I. Abdollahpour, A.S.M. Abdulle, N.D. Abebe, H.N. Abraha, L.J. Abu-Raddad, A. Abualhasan, I.A. Adedeji, S.M. Advani, M. Afarideh, M. Afshari, M. Aghaali, D. Agius, S. Agrawal, A. Ahmadi, E. Ahmadian, E. Ahmadpour, M.B. Ahmed, M.E. Akbari, T. Akinyemiju, Z. Al-Aly, A.M. AlAbdulKader, F. Alahdab, T. Alam, G.M. Alamene, B.T.T. Alemnew, K.A. Alene, C. Alinia, V. Alipour, S.M. Aljunid, F.A. Bakeshei, M.A.H. Almadi, A. Almasi-Hashiani, U. Alsharif, S. Alsowaidi, N. Alvis-Guzman, E. Amini, S. Amini, Y.A. Amoako, Z. Anbari, N.H. Anber, C.L. Andrei, M. Anjomshoa, F. Ansari, A. Ansariadi, S.C.Y. Appiah, M. Arab-Zozani, J. Arabloo, Z. Arefi, O. Aremu, H.A. Areri, A. Artaman, H. Asayesh, E.T. Asfaw, A.F. Ashagre, R. Assadi, B. Ataeinia, H.T. Atalay, Z. Ataro, S. Atique, M. Ausloos, L. Avila-Burgos, E. Avokpaho, A. Awasthi, N. Awoke, B.P. Ayala Quintanilla, M.A. Ayanore, H.T. Ayele, E. Babaee, U. Bacha, A. Badawi, M. Bagherzadeh, E. Bagli, S. Balakrishnan, A. Balouchi, T.W. Barnighausen, R.J. Battista, M. Behzadifar, M. Behzadifar, B.B. Bekele, Y.B. Belay, Y.M. Belayneh, K.K.S. Berfield, A. Berhane, E. Bernabe, M. Beuran, N. Bhakta, K. Bhattacharyya, B. Biadgo, A. Bijani, M.S. Bin Sayeed, C. Birungi, C. Bisignano, H. Bitew, T. Bjorge, A. Bleyer, K.A. Bogale, H.A. Bojia, A.M. Borzi, C. Bosetti, I.R. Bou-Orm, H. Brenner, J.D. Brewer, A.N. Briko, N.I. Briko, M.T. Bustamante-Teixeira, Z.A. Butt, G. Carreras, J.J. Carrero, F. Carvalho, C. Castro, F. Castro, F. Catala-Lopez, E. Cerin, Y. Chaiah, W.F. Chanie, V.K. Chattu, P. Chaturvedi, N.S. Chauhan, M. Chehrazi, P.P. Chiang, T.Y. Chichiabellu, O.G. Chido-Amajuoyi, O. Chimed-Ochir, J.J. Choi, D.J. Christopher, D.T. Chu, M.M. Constantin, V.M. Costa, E. Crocetti, C.S. Crowe, M.P. Curado, S.M.A. Dahlawi, G. Damiani, A.H. Darwish, A. Daryani, J. das Neves, F.M. Demeke, A.B. Demis, B.W. Demissie, G.T. Demoz, E. Denova-Gutierrez, A. Derakhshani, K.S. Deribe, R. Desai, B.B. Desalegn, M. Desta, S. Dey, S.D. Dharmaratne, M. Dhimal, D. Diaz, M.T.T. Dinberu, S. Djalalinia, D.T. Doku, T.M. Drake, M. Dubey, E. Dubljanin, E.E. Duken, H. Ebrahimi, A. Effiong, A. Eftekhari, I. El Sayed, M.E.S. Zaki, S.I. El-Jaafary, Z. El-Khatib, D.A. Elemineh, H. Elkout, R.G. Ellenbogen, A. Elsharkawy, M.H. Emamian, D.A. Endalew, A.Y. Endries, B. Eshrati, I. Fadhil, V. Fallah, M. Faramarzi, M.A. Farhangi, A. Farioli, F. Farzadfar, N. Fentahun, E. Fernandes, G.T. Feyissa, I. Filip, F. Fischer, J.L. Fisher, L.M. Force, M. Foroutan, M. Freitas, T. Fukumoto, N.D. Futran, S. Gallus, F.G. Gankpe, R.T. Gayesa, T.T. Gebrehiwot, G.G. Gebremeskel, G.A. Gedefaw, B.K. Gelaw, B. Geta, S. Getachew, K.E. Gezae, M. Ghafourifard, A. Ghajar, A. Ghashghaee, A. Gholamian, P.S. Gill, T.T.G. Ginindza, A. Girmay, M. Gizaw, R.S. Gomez, S.V. Gopalani, G. Gorini, B.N.G. Goulart, A. Grada, M. Ribeiro Guerra, A.L.S. Guimaraes, P.C. Gupta, R. Gupta, K. Hadkhale, A. Haj-Mirzaian, A. Haj-Mirzaian, R.R. Hamadeh, S. Hamidi, L.K. Hanfore, J.M. Haro, M. Hasankhani, A. Hasanzadeh, H.Y. Hassen, R.J. Hay, S.I. Hay, A. Henok, N.J. Henry, C. Herteliu, H.D. Hidru, C.L. Hoang, M.K. Hole, P. Hoogar, N. Horita, H.D. Hosgood, M. Hosseini, M. Hosseinzadeh, M. Hostiuc, S. Hostiuc, M. Househ, M.M. Hussen, B. Ileanu, M.D. Ilic, K. Innos, S.S.N. Irvani, K.R. Iseh, S.M.S. Islam, F. Islami, N. Jafari Balalami, M. Jafarinia, L. Jahangiry, M.A. Jahani, N. Jahanmehr, M. Jakovljevic, S.L. James, M. Javanbakht, S. Jayaraman, S.H. Jee, E. Jenabi, R.P. Jha, J.B. Jonas, J. Jonnagaddala, T. Joo, S.B. Jungari, M. Jurisson, A. Kabir, F. Kamangar, A. Karch, N. Karimi, A. Karimian, A. Kasaeian, G.G. Kasahun, B. Kassa, T.D. Kassa, M.W. Kassaw, A. Kaul, P.N. Keiyoro, A.G. Kelbore, A.A. Kerbo, Y.S. Khader, M. Khalilarjmandi, E.A. Khan, G. Khan, Y.H. Khang, K. Khatab, A. Khater, M. Khayamzadeh, M. Khazaee-Pool, S. Khazaei, A.T. Khoja, M.H. Khosravi, J. Khubchandani, N. Kianipour, D. Kim, Y.J. Kim, A. Kisa, S. Kisa, K. Kissimova-Skarbek, H. Komaki, A. Koyanagi, K.J. Krohn, B.K. Bicer, N. Kugbey, V. Kumar, D. Kuupiel, C. La Vecchia, D.P. Lad, E.A. Lake, A.M. Lakew, D.K. Lal, F.H. Lami, Q. Lan, S. Lasrado, P. Lauriola, J.V. Lazarus, J. Leigh, C.T. Leshargie, Y. Liao, M.A. Limenih, S. Listl, A.D. Lopez, P.D. Lopukhov, R. Lunevicius, M. Madadin, S. Magdeldin, H.M.A. El Razek, A. Majeed, A. Maleki, R. Malekzadeh, A. Manafi, N. Manafi, W.A. Manamo, M. Mansourian, M.A. Mansournia, L.G. Mantovani, S. Maroufizadeh, S.M.S. Martini, T.P. Mashamba-Thompson, B.B. Massenburg, M.T. Maswabi, M.R. Mathur, C. McAlinden, M. McKee, H.A.A. Meheretu, R. Mehrotra, V. Mehta, T. Meier, Y.A. Melaku, G.G. Meles, H.G. Meles, A. Melese, M. Melku, P.T.N. Memiah, W. Mendoza, R.G. Menezes, S. Merat, T.J. Meretoja, T. Mestrovic, B. Miazgowski, T. Miazgowski, K.M.M. Mihretie, T.R. Miller, E.J. Mills, S.M. Mir, H. Mirzaei, H.R. Mirzaei, R. Mishra, B. Moazen, D.K. Mohammad, K.A. Mohammad, Y. Mohammad, A.M. Darwesh, A. Mohammadbeigi, H. Mohammadi, M. Mohammadi, M. Mohammadian, A. Mohammadian-Hafshejani, M. Mohammadoo-Khorasani, R. Mohammadpourhodki, A.S. Mohammed, J.A. Mohammed, S. Mohammed, F. Mohebi, A.H. Mokdad, L. Monasta, Y. Moodley, M. Moosazadeh, M. Moossavi, G. Moradi, M. Moradi-Joo, M. Moradi-Lakeh, F. Moradpour, L. Morawska, J. Morgado-da-Costa, N. Morisaki, S.D. Morrison, A. Mosapour, S.M. Mousavi, A.A. Muche, O.S.S. Muhammed, J. Musa, A.R. Nabhan, M. Naderi, A.J. Nagarajan, G. Nagel, A. Nahvijou, G. Naik, F. Najafi, L. Naldi, H.S. Nam, N. Nasiri, J. Nazari, I. Negoi, S. Neupane, P.A. Newcomb, H.A. Nggada, J.W. Ngunjiri, C.T. Nguyen, L. Nikniaz, D.N.A. Ningrum, Y.L. Nirayo, M.R. Nixon, C.A. Nnaji, M. Nojomi, S. Nosratnejad, M.N. Shiadeh, M.S. Obsa, R. Ofori-Asenso, F.A. Ogbo, I.H. Oh, A.T. Olagunju, T.O. Olagunju, M.M. Oluwasanu, A.E. Omonisi, O.E. Onwujekwe, A.M. Oommen, E. Oren, D.D.V. Ortega-Altamirano, E. Ota, S.S. Otstavnov, M.O. Owolabi, A.M. P, J.R. Padubidri, S. Pakhale, A.H. Pakpour, A. Pana, E.K. Park, H. Parsian, T. Pashaei, S. Patel, S.T. Patil, A. Pennini, D.M. Pereira, C. Piccinelli, J.D. Pillay, M. Pirestani, F. Pishgar, M.J. Postma, H. Pourjafar, F. Pourmalek, A. Pourshams, S. Prakash, N. Prasad, M. Qorbani, M. Rabiee, N. Rabiee, A. Radfar, A. Rafiei, F. Rahim, M. Rahimi, M.A. Rahman, F. Rajati, S.M. Rana, S. Raoofi, G.K. Rath, D.L. Rawaf, S. Rawaf, R.C. Reiner, A.M.N. Renzaho, N. Rezaei, A. Rezapour, A.I. Ribeiro, D. Ribeiro, L. Ronfani, E.M. Roro, G. Roshandel, A. Rostami, R.S. Saad, P. Sabbagh, S. Sabour, B. Saddik, S. Safiri, A. Sahebkar, M.R. Salahshoor, F. Salehi, H. Salem, M.R. Salem, H. Salimzadeh, J.A. Salomon, A.M. Samy, J. Sanabria, M.M. Santric Milicevic, B. Sartorius, A. Sarveazad, B. Sathian, M. Satpathy, M. Savic, M. Sawhney, M. Sayyah, I.J.C. Schneider, B. Schottker, M. Sekerija, S.G. Sepanlou, M. Sepehrimanesh, S. Seyedmousavi, F. Shaahmadi, H. Shabaninejad, M. Shahbaz, M.A. Shaikh, A. Shamshirian, M. Shamsizadeh, H. Sharafi, Z. Sharafi, M. Sharif, A. Sharifi, H. Sharifi, R. Sharma, A. Sheikh, R. Shirkoohi, S.R. Shukla, S. Si, S. Siabani, D.A.S. Silva, D.G.A. Silveira, A. Singh, J.A. Singh, S. Sisay, F. Sitas, E. Sobngwi, M. Soofi, J.B. Soriano, V. Stathopoulou, M.B. Sufiyan, R. Tabares-Seisdedos, T. Tabuchi, K. Takahashi, O.R. Tamtaji, M.R. Tarawneh, S.G. Tassew, P. Taymoori, A. Tehrani-Banihashemi, M.H. Temsah, O. Temsah, B.E. Tesfay, F.H. Tesfay, M.Y. Teshale, G.A. Tessema, S. Thapa, K.G. Tlaye, R. Topor-Madry, M.R. Tovani-Palone, E. Traini, B.X. Tran, K.B. Tran, A.G. Tsadik, I. Ullah, O.A. Uthman, M. Vacante, M. Vaezi, P. Varona Perez, Y. Veisani, S. Vidale, F.S. Violante, V. Vlassov, S.E. Vollset, T. Vos, K. Vosoughi, G.T. Vu, I.S. Vujcic, H. Wabinga, T.M. Wachamo, F.S. Wagnew, Y. Waheed, F. Weldegebreal, G.T. Weldesamuel, T. Wijeratne, D.Z. Wondafrash, T.E. Wonde, A.B. Wondmieneh, H.M. Workie, R. Yadav, A. Yadegar, A. Yadollahpour, M. Yaseri, V. Yazdi-Feyzabadi, A. Yeshaneh, M.A. Yimam, E.M. Yimer, E. Yisma, N. Yonemoto, M.Z. Younis, B. Yousefi, M. Yousefifard, C. Yu, E. Zabeh, V. Zadnik, T.Z. Moghadam, Z. Zaidi, M. Zamani, H. Zandian, A. Zangeneh, L. Zaki, K. Zendehdel, Z.M. Zenebe, T.A. Zewale, A. Ziapour, S. Zodpey, C.J.L. Murray, Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA oncology (2019)."},{"issue":"3","key":"10.1016\/j.bcp.2020.113943_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12307-011-0083-6","article-title":"Homing of cancer cells to the bone","volume":"4","author":"Mishra","year":"2011","journal-title":"Cancer Microenviron"},{"issue":"6","key":"10.1016\/j.bcp.2020.113943_b0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s11914-018-0480-6","article-title":"Osteoblastic Factors in Prostate Cancer Bone Metastasis","volume":"16","author":"Lin","year":"2018","journal-title":"Current osteoporosis reports"},{"key":"10.1016\/j.bcp.2020.113943_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.urology.2015.12.039","article-title":"Biology of Bone Metastases in Prostate Cancer","volume":"92","author":"Hensel","year":"2016","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.bcp.2020.113943_b0030","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer research"},{"issue":"2","key":"10.1016\/j.bcp.2020.113943_b0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pros.10040","article-title":"The flare in alkaline phosphatase activity post-orchidectomy predicts which patient may benefit from early chemotherapy in metastatic prostate cancer","volume":"50","author":"Pelger","year":"2002","journal-title":"The Prostate"},{"issue":"5","key":"10.1016\/j.bcp.2020.113943_b0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10585-008-9175-1","article-title":"Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition","volume":"25","author":"McCabe","year":"2008","journal-title":"Clin Exp Metastasis"},{"issue":"17","key":"10.1016\/j.bcp.2020.113943_b0045","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1158\/0008-5472.CAN-04-4188","article-title":"Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo","volume":"65","author":"van der Pluijm","year":"2005","journal-title":"Cancer research"},{"key":"10.1016\/j.bcp.2020.113943_b0050","doi-asserted-by":"crossref","first-page":"eaai9338","DOI":"10.1126\/scitranslmed.aai9338","article-title":"kinase: A target for treatment of cancer-induced bone destruction and osteoporosis","author":"Andrade","year":"2017","journal-title":"Sci Transl Med 9(374)"},{"issue":"7","key":"10.1016\/j.bcp.2020.113943_b0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14728222.2010.492779","article-title":"PAK1 as a therapeutic target","volume":"14","author":"Kichina","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bcp.2020.113943_b0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcancer.2018.01.006","article-title":"P21 activated kinase signaling in cancer","volume":"54","author":"Rane","year":"2019","journal-title":"Seminars in cancer biology"},{"key":"10.1016\/j.bcp.2020.113943_b0065","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.28003","article-title":"P21 activated kinases: structure, regulation, and functions","volume":"5","author":"Rane","year":"2014","journal-title":"Small GTPases"},{"issue":"6","key":"10.1016\/j.bcp.2020.113943_b0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1892","article-title":"p21-activated kinases in cancer","volume":"6","author":"Kumar","year":"2006","journal-title":"Nature reviews. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2020.113943_b0075","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1074\/jbc.M112.424770","article-title":"P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor beta expression and enhanced matrix metalloproteinase 9 secretion","volume":"288","author":"Goc","year":"2013","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"10.1016\/j.bcp.2020.113943_b0080","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbamcr.2015.02.023","article-title":"P21 activated kinase-1 mediates transforming growth factor beta1-induced prostate cancer cell epithelial to mesenchymal transition","volume":"1853","author":"Al-Azayzih","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.bcp.2020.113943_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.518","article-title":"Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion","volume":"7","author":"Najahi-Missaoui","year":"2019","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"10.1016\/j.bcp.2020.113943_b0090","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.nano.2016.01.003","article-title":"Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo","volume":"12","author":"Al-Azayzih","year":"2016","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2020.113943_b0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10555-017-9719-4","article-title":"Current perspectives on bone metastases in castrate-resistant prostate cancer","volume":"37","author":"Logothetis","year":"2018","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"10.1016\/j.bcp.2020.113943_b0100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"The Molecular Taxonomy of Primary Prostate Cancer","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2020.113943_b0105","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","article-title":"Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories","volume":"34","author":"Gerhauser","year":"2018","journal-title":"Cancer Cell"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2020.113943_b0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18632\/oncoscience.482","article-title":"Genome atlas analysis based profiling of Akt pathway genes in the early and advanced human prostate cancer","volume":"6","author":"Alwhaibi","year":"2019","journal-title":"Oncoscience"},{"issue":"1","key":"10.1016\/j.bcp.2020.113943_b0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/cancers3010478","article-title":"From prostate to bone: key players in prostate cancer bone metastasis","volume":"3","author":"Thobe","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.bcp.2020.113943_b0120","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/pros.20787","article-title":"Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins","volume":"68","author":"Kaur","year":"2008","journal-title":"The Prostate"},{"issue":"1","key":"10.1016\/j.bcp.2020.113943_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrc3645","article-title":"PAK signalling during the development and progression of cancer","volume":"14","author":"Radu","year":"2014","journal-title":"Nature reviews. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2020.113943_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BST20160134","article-title":"Targeting PAK1","volume":"45","author":"Semenova","year":"2017","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"10.1016\/j.bcp.2020.113943_b0135","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acsmedchemlett.5b00398","article-title":"Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety","volume":"6","author":"Ndubaku","year":"2015","journal-title":"ACS Med Chem Lett"},{"issue":"47","key":"10.1016\/j.bcp.2020.113943_b0140","doi-asserted-by":"crossref","first-page":"15764","DOI":"10.1021\/ja805555a","article-title":"Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes","volume":"130","author":"Maksimoska","year":"2008","journal-title":"J Am Chem Soc"},{"issue":"20","key":"10.1016\/j.bcp.2020.113943_b0145","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1073\/pnas.0911863107","article-title":"Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth","volume":"107","author":"Murray","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.bcp.2020.113943_b0150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/acsmedchemlett.6b00322","article-title":"Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors","volume":"7","author":"McCoull","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"10.1016\/j.bcp.2020.113943_b0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chembiol.2008.03.005","article-title":"An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase","volume":"15","author":"Deacon","year":"2008","journal-title":"Chem Biol"},{"issue":"7","key":"10.1016\/j.bcp.2020.113943_b0160","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1021\/acsmedchemlett.5b00102","article-title":"Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor","volume":"6","author":"Karpov","year":"2015","journal-title":"ACS Med Chem Lett"},{"issue":"25","key":"10.1016\/j.bcp.2020.113943_b0165","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/onc.2009.114","article-title":"The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt","volume":"28","author":"Somanath","year":"2009","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bcp.2020.113943_b0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1242\/dmm.030403","article-title":"Mouse models of metastasis: progress and prospects","volume":"10","author":"Gomez-Cuadrado","year":"2017","journal-title":"Disease models & mechanisms"},{"key":"10.1016\/j.bcp.2020.113943_b0175","author":"Jayarangaiah","year":"2020","journal-title":"StatPearls, Treasure Island (FL)"},{"issue":"1","key":"10.1016\/j.bcp.2020.113943_b0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1593\/neo.10998","article-title":"Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer","volume":"13","author":"McCabe","year":"2011","journal-title":"Neoplasia"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:12:57Z","timestamp":1757769177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220301714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"alternative-id":["S0006295220301714"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113943","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113943"}}